Tuesday, March 5, 2019

Glenmark Pharma appoints Alessandro Riva as CEO of its new innovation company in US

Glenmark Pharma appoints Alessandro Riva as CEO of its new innovation company in US "Alessandro is currently Executive Vice President, Oncology Therapeutics and Cell Therapy for Gilead Sciences. The appointment is effective April 2, 2019," Glenmark Pharma said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2EBSrtG
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...